Results 211 to 220 of about 98,461 (251)

Pathogenesis and research progress of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis. [PDF]

World J Hepatol
Shan GY, Wan H, Zhang YX, Cheng JY, Qiao DR, Liu YY, Shi WN, Li HJ.   +7 more
europepmc   +1 more source

No Significant Effects of Ethyl-Eicosapentanoic Acid on Histologic Features of Nonalcoholic Steatohepatitis in a Phase 2 Trial [PDF]

, 2014
Arun J. Sanyal, Manal F. Abdelmalek, Ayako Suzuki, Oscar W. Cummings, Mario Chojkier   +4 more
openalex   +1 more source

Exosomal novel-miRNA-126 mediates vascular endothelial dysfunction by targeting AhR-NLRP3 pathway in nonalcoholic steatohepatitis. [PDF]

Sci Rep
Chen Q, Ye L, Huang L, You H, Yu X, Wang K, Xiong S, Liao W, Wang X, Li H, Chen Y.   +10 more
europepmc   +1 more source

Surgical Implications for Nonalcoholic Steatohepatitis-Related Hepatocellular Carcinoma. [PDF]

Cancers (Basel)
Anbarasu CR, Williams-Perez S, Camp ER, Erstad DJ.   +3 more
europepmc   +1 more source

Oligonucleotide therapies for nonalcoholic steatohepatitis. [PDF]

Mol Ther Nucleic Acids
Li S, Xiong F, Zhang S, Liu J, Gao G, Xie J, Wang Y.   +6 more
europepmc   +1 more source

Exploring the mechanisms of tetrahydrocurcumin in ameliorating nonalcoholic steatohepatitis based on network pharmacology and gut microbiota analysis <i>in vivo</i> and <i>in vitro</i>. [PDF]

Front Microbiol
Chen K, Wang J, Luo S, Quan Y, Wei P, Fu J, Ma J, Yang Y, Liu Y, Gao Z.   +9 more
europepmc   +1 more source

Costs associated with nonalcoholic steatohepatitis disease progression in Medicare patients: a retrospective cohort study. [PDF]

J Comp Eff Res
Kim Y, Medicis J, Davis M, Nunag D, Gish R.   +4 more
europepmc   +1 more source

Analysis of Abnormal Iron Metabolism and Efficacy of Iron Reduction Therapy in Patients With Nonalcoholic Steatohepatitis

, 2011
Shingo Tanaka, Koji Miyanishi, Masayoshi Kobune, Hiroyuki Nagashima, Tsutomu Sato, Yasushi Sato, Rishu Takimoto, Junji Kato   +7 more
openalex   +1 more source

The methyltransferase MLL4 promotes nonalcoholic steatohepatitis by enhancing NF-κB signaling. [PDF]

J Biol Chem
Lee J, An H, Kim CS, Lee S.
europepmc   +1 more source

Корекція Ендотоксикозу І Синдрому Пероксидації У Хворих На Подагру В Поєднанні З Неалкогольним Стеатогепатитом = Lipid Peroxidation And Endotoxemia Syndrome Сorrection In Patients With Gout Combined With Nonalcoholic Steatohepatitis

, 2015
Svitlana Smiyan, S. V. Danchak
openalex   +2 more sources